784 filings
Page 21 of 40
424B4
CRVO
CervoMed Inc
19 Jan 18
Prospectus supplement with pricing info
12:00am
8-K
CRVO
CervoMed Inc
19 Jan 18
Diffusion Pharmaceuticals Announces $12 Million Underwritten Public Offering
12:00am
CORRESP
CRVO
CervoMed Inc
17 Jan 18
Correspondence with SEC
12:00am
EFFECT
CRVO
CervoMed Inc
17 Jan 18
Notice of effectiveness
12:00am
CORRESP
CRVO
CervoMed Inc
16 Jan 18
Correspondence with SEC
12:00am
S-1/A
CRVO
CervoMed Inc
IPO registration (amended)
16 Jan 18
12:00am
4
CRVO
CervoMed Inc
4 Jan 18
Diffusion Pharmaceuticals / Mark T Giles ownership change
12:00am
4
CRVO
CervoMed Inc
4 Jan 18
Diffusion Pharmaceuticals / ROBERT R RUFFOLO ownership change
12:00am
4
CRVO
CervoMed Inc
4 Jan 18
Diffusion Pharmaceuticals / John Gainer ownership change
12:00am
4
CRVO
CervoMed Inc
4 Jan 18
Diffusion Pharmaceuticals / Ben Shealy ownership change
12:00am
4
CRVO
CervoMed Inc
4 Jan 18
Diffusion Pharmaceuticals / ALAN G LEVIN ownership change
12:00am
4
CRVO
CervoMed Inc
4 Jan 18
Diffusion Pharmaceuticals / David G Kalergis ownership change
12:00am
4
Thomas E Byrne
4 Jan 18
Diffusion Pharmaceuticals / Thomas E Byrne ownership change
12:00am
4
Adams Robert W
4 Jan 18
Diffusion Pharmaceuticals / Robert W Adams ownership change
12:00am
8-K
CRVO
CervoMed Inc
29 Dec 17
Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme
12:00am
UPLOAD
CRVO
CervoMed Inc
29 Dec 17
Letter from SEC
12:00am
S-1
CRVO
CervoMed Inc
IPO registration
20 Dec 17
12:00am
8-K
CRVO
CervoMed Inc
20 Nov 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
10-Q
2017 Q3
CRVO
CervoMed Inc
Quarterly report
13 Nov 17
12:00am
8-K
CRVO
CervoMed Inc
13 Nov 17
Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am